The $100K Domino Effect: Why Global CDMOs Are Blacklisting Unverified Scientific Equipment Suppliers
Scientific Equipment Suppliers evaluation is no longer a simple procurement task—in 2026, it has escalated into a critical financial risk management issue for global bio-ventures and CDMOs. As the biopharmaceutical sector aggressively shifts toward complex modalities like Antibody-Drug Conjugates (ADCs), a single minor process deviation can trigger a catastrophic domino effect, leading to immediate FDA … Read more